Molecular Biology Research

Bacteria Use Rapid Defence Mechanism

10. 8. 2016 | HZI researchers elucidate the mechanism used by yersinia bacteria to quickly evade the attack of the immune system, together with colleagues from the University of Umeå in Sweden.
When bacteria enter the body of a human or animal, they are recognised as foreign by the immune system. The immune cells in turn try to eliminate these foreign bodies. Scientists of the Helmholtz Centre for Infection Research HZI in Braunschweig, together with colleagues from the University of Umeå in Sweden, discovered how Yersinia bacteria kill immune cells at first contact: they multiply the genetic information for their pathogenic tools and simultaneously inject substances into the immune cells that rapidly inactivate and kill these cells.

Bacteria of the Yersinia genus can cause serious intestinal disease, and even the plague in humans. The genetic information for the tools that make Yersinia bacteria so harmful is situated on a separate DNA molecule, called the virulence plasmid. Without this ring-shaped DNA that is independent of the other genetic material in the bacterial cell, Yersinia bacteria are harmless. The virulence plasmid includes the blueprint for a molecular 'syringe' that is used by the bacteria to inject substances into the host cells to initiate their death. The researchers already knew that the bacteria produce large amounts of these molecular syringes during infection, but the underlying mechanisms were not known in detail.

To solve this riddle, the researchers working with Hans Wolf-Watz and Tomas Edgren at the University of Umeå, grew the Yersinia pseudotuberculosis pathogen in culture vessels and simulated an infection. They sequenced the entire genetic material of these activated bacteria and compared it to resting bacteria. The result: In the simulated infection, the bacteria suddenly had four copies of virulence plasmids per cell, while just one to two copies per cell are present in the resting state.

Prof. Petra Dersch
Bild vergrößern
Prof. Petra Dersch
At this point, HZI researchers working with Petra Dersch joined the project. Dersch is head of the Molecular Infection Biology department at the HZI. The researchers used Yersinia-infected mice to investigate how the increased number of plasmid copies is produced in viable organisms. "The bacteria become real virulent only once they have four plasmid copies," says Dersch. "This is an unprecedented finding and we succeeded to elucidate the underlying mechanism using the latest sequencing technology at the HZI."

Aaron Nuss, a postdoctoral student in Dersch's department, used an advanced method to isolate all transcripts of the bacterial DNA from the infected mice and then sequenced this material. This kind of transcripts, the cells' RNA, can be used to determine which genes are active and used for the production of proteins at any given moment. It was noted that an enzyme called replicase that multiplies the plasmid is one of the proteins produced at higher levels during an infection. In the resting state, the production of this enzyme is limited by certain factors.

But the reverse process sets in upon contact with an immune cell: The bacteria immediately remove the inhibitory factors and produce more replicase, which then multiplies the virulence plasmid. This is equivalent to the Yersinia bacteria revving up their defence mechanisms. "The Yersinia bacteria start this program mainly upon contact with immune cells in order to protect themselves from attack as quickly as possible," says Petra Dersch. "They expend so much energy in this process that they even need to arrest their growth temporarily."

The new insights are the result of a close cooperation: Hans Wolf-Watz, the department head from Umeå, completed a three-month research visit to Dersch's department in the spring, and researcher Tomas Edgren spent two weeks at the HZI. The scientists completed most of the experiments on infected mice during this time. The publication in the scientific journal Science is not the end of this cooperation: "We aim to continue to elucidate the mechanisms of the Yersinia infection in our collaborative work, since this may lead us to certain points of attack for potential medications rendering the bacteria harmless," says Petra Dersch.
  (© Umea University, Helmholtz Centre for Infection Research)

More information

Additional articles on this topic


  • H. Wang, K. Avican, A. Fahlgren, S. Erttmann, A. M. Nuss, P. Dersch, M. Fallman, T. Edgren, H. Wolf-Watz: Increased Plasmid Copy-number is Essential for Yersinia T3SS Function and Virulence, Science, 2016, DOI: 10.1126/science.aaf7501


  1. Read what our members say about AcademiaNet.

No more excuses!

  1. Please download the brochure "No more excuses" and read more about female experts in Europe, and about AcademiaNet.


  1. AcademiaNet at a crossroads – a look back and future perspectives

    The Robert Bosch Foundation (RBS) has founded AcademiaNet and funded the platform from the beginning. They now have to end the funding at a time when AcademiaNet starts to gain momentum. We spoke with Dr Katrin Rehak-Nitsche, Senior Vice President for Science and Research at the RBS, about the situation.

  2. "We are missing out on a lot of potential…”

    Interview with AcademiaNet member Eva-Maria Feichtner

  3. Narcissism: not only an individual failing

    Interview with AcademiaNet member Agnieszka Golec de Zavala

  4. "Embrace the Uncertainty"

    Interview with AcademiaNet member Prof. Dr. Helga Nowotny

  5. Film and television tell children who can be scientists

    Roles on the screen largely reinforce the message that scientists are white men.